AstraZeneca
AZN
#70
Rank
โ‚ฌ219.26 B
Marketcap
141,38ย โ‚ฌ
Share price
-0.84%
Change (1 day)
-4.98%
Change (1 year)

Revenue for AstraZeneca (AZN)

Revenue in 2026 (TTM): โ‚ฌ52.82 Billion

According to AstraZeneca's latest financial reports the company's current revenue (TTM ) is โ‚ฌ54.64 Billion. In 2025 the company made a revenue of โ‚ฌ50.00 Billion a decrease over the revenue in the year 2024 that were of โ‚ฌ51.96 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for AstraZeneca from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ52.82 B5.65%
2025 โ‚ฌ50.00 B-3.77%
2024 โ‚ฌ51.96 B25.39%
2023 โ‚ฌ41.44 B0.23%
2022 โ‚ฌ41.34 B25.14%
2021 โ‚ฌ33.03 B52.68%
2020 โ‚ฌ21.64 B-0.58%
2019 โ‚ฌ21.76 B12.73%
2018 โ‚ฌ19.30 B3.13%
2017 โ‚ฌ18.72 B-14.38%
2016 โ‚ฌ21.86 B-3.23%
2015 โ‚ฌ22.59 B3.66%
2014 โ‚ฌ21.80 B17.1%
2013 โ‚ฌ18.61 B-11.96%
2012 โ‚ฌ21.14 B-18.24%
2011 โ‚ฌ25.86 B3.41%
2010 โ‚ฌ25.01 B9.24%
2009 โ‚ฌ22.89 B1.29%
2008 โ‚ฌ22.60 B11.66%
2007 โ‚ฌ20.24 B0.9%
2006 โ‚ฌ20.06 B-0.76%
2005 โ‚ฌ20.21 B28%
2004 โ‚ฌ15.79 B5.5%
2003 โ‚ฌ14.97 B-11.31%
2002 โ‚ฌ16.88 B-36.65%
2001 โ‚ฌ26.64 B38.57%
2000 โ‚ฌ19.23 B4.96%
1999 โ‚ฌ18.32 B121.27%
1998 โ‚ฌ8.27 B9.72%
1997 โ‚ฌ7.54 B-21.63%
1996 โ‚ฌ9.63 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ87.19 B 59.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ50.47 B-7.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ56.71 B 3.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ40.18 B-26.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ70.93 B 29.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ50.61 B-7.37%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚ฌ8.92 B-83.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ59.27 B 8.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ43.79 B-19.85%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ39.48 B-27.74%๐Ÿ‡ฌ๐Ÿ‡ง UK